Follow-up
Further Inpatient Care
- Inpatient care for patients with corneal ulcers is not required.
Further Outpatient Care
- Outpatient care for patients with corneal ulcers is necessary only if systemic manifestations are present.
Complications
- The most serious complications for these patients are systemic because, in many cases, their underlying conditions are associated with a high mortality rate.
- The most serious ocular complication includes corneal perforation with secondary infections, corneal scarring, and secondary cataracts and glaucoma.
Patient Education
- For excellent patient education resources, visit eMedicine's Eye and Vision Center. Also, see eMedicine's patient education article Corneal Ulcer.
Miscellaneous
Medicolegal Pitfalls
- Patients with an undiagnosed corneal ulcer must be referred to a rheumatologist because the underlying diagnosis could have significant implications for their general health and life, and the ophthalmologist should be careful not to overlook such an underlying diagnosis.
Special Concerns
- Because of the possibility of recurrence, any later surgical interventions should be performed with concurrent immunosuppression, even in apparently quiet eyes.
More on Ulcer, Corneal |
| Overview: Ulcer, Corneal |
| Differential Diagnoses & Workup: Ulcer, Corneal |
| Treatment & Medication: Ulcer, Corneal |
Follow-up: Ulcer, Corneal |
| References |
| « Previous Page |
References
Asai T, Nakagami T, Mochizuki M. Three cases of corneal melting after instillation of a new nonsteroidal anti-inflammatory drug. Cornea. Feb 2006;25 (2):224-7. [Medline].
Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener''s granulomatosis. Ophthalmology. Mar 1983;90(3):279-90. [Medline].
Flach AJ. Corneal melts associated with topically applied nonsteroidal anti-inflammatory drugs. Trans Am Ophthalmol Soc. 2001;99:205-10; discussion 210-2. [Medline].
Foster CS, Forstot SL, Wilson LA. Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression. Ophthalmology. Oct 1984;91(10):1253-63. [Medline].
Guidera AC, Luchs JI, Udell IJ. Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. Ophthalmology. May 2001;108(5):936-44. [Medline].
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. Sep 1997;40(9):1725. [Medline].
Jayson MI, Jones DE. Scleritis and rheumatoid arthritis. Ann Rheum Dis. Jul 1971;30(4):343-7. [Medline].
Lambiase A, Rama P, Bonini S, et al. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N Engl J Med. Apr 23 1998;338(17):1174-80. [Medline].
Lambiase A, Bonini S, Aloe L, et al. Anti-inflammatory and healing properties of nerve growth factor in immune corneal ulcers with stromal melting. Arch Ophthalmol. Oct 2000;118(10):1446-9. [Medline].
Paroli MP, Pinca M, Speranza S. Paracentral corneal melting in a patient with Vogt-Koyanagi-Harada's syndrome, psoriasis, and Hashimoto's thyroiditis. Ocul Immunol Inflamm. Dec 2003;11(4):309-13. [Medline].
Robin JB, Schanzlin DJ, Meisler DM, et al. Ocular involvement in the respiratory vasculitides. Surv Ophthalmol. Sep-Oct 1985;30(2):127-40. [Medline].
Schechter BA, Rand WJ, Nagler RS. Corneal melt after amniotic membrane transplant. Cornea. Jan 2005;24(1):106-7. [Medline].
Vanathi M, Sharma N, Titiyal JS. Tectonic grafts for corneal thinning and perforations. Cornea. Nov 2002;21(8):792-7. [Medline].
West RH, Barnett AJ. Ocular involvement in scleroderma. Br J Ophthalmol. Dec 1979;63(12):845-7. [Medline].
Further Reading
Keywords
corneal melt, chronic serpiginous ulcer of the cornea, ulcus rodens, corneoscleral melting
Follow-up: Ulcer, Corneal